The Enterprise Value as of December 2025 (TTM) for Chordia Therapeutics Inc. (190A.T) is 4.97B

According to Chordia Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.97B. This represents a change of -60.24% compared to the average of 12.50B of the last 4 quarters.

Chordia Therapeutics Inc. (190A.T) Historical Enterprise Value (quarterly & annually)

How has 190A.T Enterprise Value performed in the past?

The mean historical Enterprise Value of Chordia Therapeutics Inc. over the last ten years is 13.27B. The current 4.97B Enterprise Value has changed 3.65% with respect to the historical average. Over the past ten years (40 quarters), 190A.T's Enterprise Value was at its highest in in the August 2024 quarter at 48.46B. The Enterprise Value was at its lowest in in the May 2023 quarter at -5317331000.00.

Chordia Therapeutics Inc. (190A.T) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Chordia Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chordia Therapeutics Inc. (190A.T) Average Enterprise Value

How has 190A.T Enterprise Value performed in the past?

The current Enterprise Value of Chordia Therapeutics Inc. (190A.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chordia Therapeutics Inc. (190A.T) Enterprise Value vs. Peers

How is 190A.T’s Enterprise Value compared to its peers?

Chordia Therapeutics Inc.’s Enterprise Value is less than ADR120S, Inc. (6.99B), less than Tsubota Laboratory Incorporated (7.78B), less than Data Horizon Corporation (8.41B), less than Solasia Pharma K.K. (6.20B), greater than Yamashita Health Care Holdings,Inc. (2.48B), greater than BrightPath Biotherapeutics Co., Ltd. (3.28B), greater than Linical Co., Ltd. (3.44B), less than OncoTherapy Science, Inc. (5.80B), less than Pharmarise Holdings Corporation (16.86B), less than K Pharma,Inc. (5.49B),

Build a custom stock screener for Chordia Therapeutics Inc. (190A.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chordia Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chordia Therapeutics Inc. (190A.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chordia Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.